India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has discovered the widespread use of industrial-grade excipients, unfit for human consumption, in the country's pharmaceutical manufacturing. Following international complaints, the CDSCO conducted investigations and inspections, revealing that unlicensed traders supplied industrial-grade gelatin, propylene glycol, and other excipients to pharmaceutical manufacturing units.
